Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price: ₹1,145.80
Market cap: ₹15,897 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 24.7×Sector 47.3×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 3 Earnings Call 3 Employee Stock Options 2 Debt & Borrowing 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Financial Results 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

9 Sep 2026 17:19 IST NSE

Debt & Borrowing

Eris Lifesciences Debt & Borrowing: ₹45 Cr

Eris Lifesciences has entered into a term loan agreement with Axis Bank Limited for ₹45 Crore to meet general liabilities.

Value: ₹45.00 Cr

Read the filing ↗

6 Aug 2026 09:38 IST BSE

Debt & Borrowing

Eris Lifesciences Debt & Borrowing: ₹64.4 Cr

Eris Lifesciences Limited has drawn down a ₹64.40 Crore working capital term loan from Axis Bank. The funds will be used to meet existing short-term liabilities.

Value: ₹64.40 Cr

Read the filing ↗